Abstract:Background With the advent of high-throughput targeted metabolic profiling techniques, the question of how to interpret and analyze the resulting vast amount of data becomes more and more important. In this work we address the reconstruction of metabolic reactions from cross-sectional metabolomics data, that is without the requirement for time-resolved measurements or specific system perturbations. Previous studies in this area mainly focused on Pearson correlation coefficients, which however are generally incapable of distinguishing between direct and indirect metabolic interactions. Results In our new approach we propose the application of a Gaussian graphical model (GGM), an undirected probabilistic graphical model estimating the conditional dependence between variables. GGMs are based on partial correlation coefficients, that is pairwise Pearson correlation coefficients conditioned against the correlation with all other metabolites. We first demonstrate the general validity of the method and its advantages over regular correlation networks with computer-simulated reaction systems. Then we estimate a GGM on data from a large human population cohort, covering 1020 fasting blood serum samples with 151 quantified metabolites. The GGM is much sparser than the correlation network, shows a modular structure with respect to metabolite classes, and is stable to the choice of samples in the data set. On the example of human fatty acid metabolism, we demonstrate for the first time that high partial correlation coefficients generally correspond to known metabolic reactions. This feature is evaluated both manually by investigating specific pairs of high-scoring metabolites, and then systematically on a literature-curated model of fatty acid synthesis and degradation. Our method detects many known reactions along with possibly novel pathway interactions, representing candidates for further experimental examination. Conclusions In summary, we demonstrate strong signatures of intracellular pathways in blood serum data, and provide a valuable tool for the unbiased reconstruction of metabolic reactions from large-scale metabolomics data sets.

A New Algorithm in the Application of Parameter Optimization in Radiotherapy

Integrated De Novo Gene Prediction and Peptide Assembly of Metagenomic Sequencing Data

Gene-Metabolite Association Prediction with Interactive Knowledge Transfer Enhanced Graph for Metabolite Production

MVML-MPI: Multi-View Multi-Label Learning for Metabolic Pathway Inference

Metabolite and reaction inference based on enzyme specificities

Exploration and Evaluation of Machine Learning-Based Models for Predicting Enzymatic Reactions

Chemical reaction vector embeddings: towards predicting drug metabolism in the human gut microbiome

A generalizable framework for unlocking missing reactions in genome-scale metabolic networks using deep learning

Exploration of bioinformatic domain based on data mining, reaction and enzyme promiscuity predictions

Prediction and integration of metabolite-protein interactions with genome-scale metabolic models

MGDHGS : Gene-bridged metabolite-disease relationships prediction via GraphSAGE and self-attention mechanism

Graph2MDA: a multi-modal variational graph embedding model for predicting microbe-drug associations

A scalable algorithm to explore the Gibbs energy landscape of genome-scale metabolic networks

Learning graph representations of biochemical networks and its application to enzymatic link prediction

A deep learning architecture for metabolic pathway prediction

Gaussian graphical modeling reconstructs pathway reactions from high-throughput metabolomics data

Predicting metabolite–disease associations based on auto-encoder and non-negative matrix factorization

Teasing out missing reactions in genome-scale metabolic networks through hypergraph learning

Predicting Metabolic Pathways of Small Molecules and Enzymes Based on Interaction Information of Chemicals and Proteins.

gapseq: informed prediction of bacterial metabolic pathways and reconstruction of accurate metabolic models

4-(4-Chlorophenyl)-3,7,7-trimethyl-1-[2-(4-nitrobenzoyl)ethyl]-4,7,8,9-tetrahydro-1H-pyrazolo[3,4-b]quinolin-5(6H)-one-ethanol (1/1).